Sched.com Conference Mobile Apps
bwge2018
has ended
Create Your Own Event
bwge2018
-
Saved To
My Schedule
Belgian Week of Gastroenterology 2018
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
Belgian Association for the Study of the Liver (BASL)
All
Session 1
Session 2
Session 3
Session 4
Belgian Group for Digestive Oncology (BGDO)
All
Session 'State of the art'
Session 1: Selected abstracts
Session 2: Highlights of the year
Symposium
Belgian Inflammatory Bowel Disease Research and Development Group (BIRD)
All
General Assembly
Session 1
Session 2
Session 3
Session 4
Belgian Network on Gastrointestinal Regulatory Mechanisms (GIREM)
All
Session 1
Belgian Pancreatic Club
All
Clinical cases session 1
Clinical cases session 2
Belgian Society for Gastrointestinal Endoscopy (BSGIE)
All
Guided e-Poster Tour
Live Transmission
Oral presentations & invited lectures
Belgian Society for Paediatric Gastroenterology and Nutrion (BeSPGHAN)
Belgian Working group on Digestive Pathology
All
Session 1
Session 2
Session 3
Session 4
Belgian Working Group on Proctology
BINAstoria
Interactive Case Report Session 1
Interactive Case Report Session 2
Oral Top Posters - Short talks
Satellite Symposia
All
Symposium
Ultrasound Course
Young BASL
All
Session 1
Session 2
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
menu
Menu
Schedule
Speakers
Search
tune
Filter sessions
Simple
Expanded
Grid
By Venue
Wednesday
, February 21
Exhibition Area (3th floor)
15:20 •
Coffee break
15:25 •
Coffee Break
15:30 •
Coffee break
15:45 •
Coffee break
Room Florentine
17:00 •
Ultrasound course "Normal anatomy and abdominal pathology for trainees in ultrasound"
Room HOPE (2nd floor)
14:00 •
An unusual cause of bleeding in a cirrhotic patient
14:20 •
A case of acute hepatitis under Nivolumab treatment
14:40 •
Endoscopic submucosal dissection of a suspicious esophageal lesion
15:00 •
Terminal ileitis after kidney transplantation: Crohn’s disease or other cause?
15:40 •
Uncommon cause of cholangiopathy in a cirrhotic patient: EUS finding
16:00 •
Infectious complications in a patient with automated low-flow ascites pump: a unique case report
16:20 •
Acute esophageal mucosal damage after Lugol staining
16:40 •
A case of portal vein aneurysm
Room LIJN (3th floor)
13:15 •
Satellite symposium: Janssen-Cilag : Targeting IL-23/-12 in Crohn’s disease : experience from across the border
13:15 •
Satellite symposium: Janssen-Cilag : Targeting IL-23/-12 in Crohn’s disease : experience from across the border
14:00 •
INVITED LECTURE: Why animal models of IBD are still relevant
14:25 •
Aberrant Muc1 and Muc13 expression in association with Par polarity complex and Vip dysfunction in a colitis T cell transfer model
14:35 •
Transcriptomic profile of inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients depend on the age at diagnosis
14:45 •
Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn’s disease
14:55 •
Endoplasmic Reticulum stress in bordering epithelium of Crohn’s disease patients with intestinal fibrosis
15:05 •
INVITED LECTURE: Benefits and limitations of pre-clinical in vitro and ex vivo work
16:00 •
Serum proteomic analysis characterizes newly diagnosed Crohn’s disease and ulcerative colitis depending on the age at diagnosis
16:10 •
Serum proteomic profiling reveals changes in inflammatory profiles with consecutive biological therapies in patients with inflammatory bowel disease
16:20 •
Protein biomarkers identify subclinical inflammation patterns in first-degree relatives of patients with inflammatory bowel disease
16:30 •
Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis
16:40 •
INVITED LECTURE: The exposome in IBD: what needs to be done?
17:00 •
Satelite symposium Pfizer: New MOAs/pathways in the IBD world
17:00 •
Satelite symposium Pfizer: New MOAs/pathways in the IBD world
17:45 •
BIRD General Assembly
Room TEUN (3th floor)
14:00 •
Diagnosis of pancreatic cystic lesions. The view of the clinician – The view of the pathologist
14:30 •
Endoscopic necrosectomy a single center experience
14:45 •
Long term outcome of patients with pancreatic duct disruption
15:00 •
Improvement of pancreatic endocrine function after endoscopic treatment of chronic pancreatitis
15:15 •
Invited Lecture: Management of autoimmune pancreatitis in 2018
16:10 •
Severe panniculitis and polyarthritis
16:20 •
A rare variant of conventional pancreatic ductal adenocarcinoma.
16:30 •
A rare cause of repetitive acute pancreatitis.
16:40 •
EUS guided Pancreaticogastrostomy
16:50 •
A rare but morphological characteristic cystic lesion of the pancreas
Room TIFFANY/SHAH (2nd floor)
14:00 •
BASL best clinical paper MSD 2017 “Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.”
14:20 •
BASL best basic paper MSD 2017 “A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.”
14:40 •
Invited Lecture: Animal models in liver disease: from law to practice
15:45 •
Starter’s talk: “Systems Serology Analysis of Human Alcoholic Liver Diseases”
15:55 •
Starter’s talk: “The role of the intrahepatic vascular resistance and its underlying mechanisms in the pathophysiology of NAFLD”
16:05 •
Invited Lecture: “Antiviral therapy: from bench to bedside.”
16:50 •
Closing Remarks
Thursday
, February 22
Exhibition Area (3th floor)
10:00 •
Coffee break
10:30 •
Coffee break
12:15 •
Oral Top Basic Posters
12:30 •
Lunch
12:45 •
Lunch
15:30 •
Coffee break
15:30 •
Coffee break
15:30 •
Coffee break
15:30 •
Coffee break
Room Florentine
17:00 •
Ultrasound course "Ultrasound in bowel pathology"
Room HOPE (2nd floor)
09:00 •
Two rare conditions at the same time after gastric bypass in a young female
09:20 •
A case of severe enteropathy
09:40 •
Probiotics in a critically ill malnourished patient: to do or not to do
10:30 •
An unusual cause of gastrojejunal anastomotic stenosis after Roux-en-Y gastric bypass
10:50 •
Adenocarcinoma of the gastroesophageal junction after bariatric surgery : Two cases reports
11:10 •
Endoluminal vacuum therapy for the treatment of esophageal anastomotic leaks
11:30 •
Unusual yellow to orange colonic mucosal appearance: what could that be?
11:50 •
Q & A - Questions and Answers
Room LIJN (3th floor)
13:15 •
Satellite symposium Takeda: PK/PD for guiding therapy with vedolizumab: lessons from clinical experience
13:15 •
Satellite symposium Takeda: PK/PD for guiding therapy with vedolizumab: lessons from clinical experience
14:00 •
INVITED LECTURE: JAK inhibitors: can they replace biologicals?
14:25 •
Thiopurine monotherapy still has a place in the treatment of patients with mild-to-moderate Crohn’s disease in the biological era
14:35 •
Ustekinumab induces clinical and biological remission in biologic refractory crohn's disease patients
14:45 •
Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments
14:55 •
Ustekinumab induces limited mucosal healing after 6 months in a real-life, prospective cohort of patients with refractory Crohn’s disease
15:05 •
INVITED LECTURE: JAK inhibitors: is the increased risk of viral infections a real threat?
16:00 •
Effectiveness and persistence of vedolizumab in patients with inflammatory bowel disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
16:10 •
Vedolizumab trough levels during induction in IBD patients: a longitudinal observational retrospective study
16:20 •
Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: a retrospective single centre experience
16:30 •
Outcome of pregnancies in vedolizumab treated female IBD patients
16:40 •
INVITED LECTURE: Initiating biological therapies in IBD: do I have to use other drugs for CD than for UC?
Room SANCY (2nd floor)
13:00 •
Guided e-Poster Tour
14:00 •
Automated digital calculation of endoscopic inflammation in ulcerative colitis: results of the red density study
14:15 •
Endobiliary radiofrequency ablation in patients with inoperable biliopancreatic tumors complicated with obstructive jaundice: the IGNITE-1 trial
14:30 •
Simple endoscopic treatment of adenoma recurrence after wide field endoscopic mucosal resection is effective: a prospective study of 1558 lesions with long term follow up
14:45 •
Self-sizing radiofrequency ablation balloon for eradication of Barrett's esophagus: results of an international multicenter randomized trial comparing three different treatment regimens.
15:00 •
Invited Lecture: ESGE quality indicators for lower GI endoscopy
16:00 •
An international survey of colorectal polypectomy practice demonstrates encouraging adherence to published guidance
16:12 •
Higher mean Boston bowel preparation scale scores with 1L PEG-based NER1006 versus 2L PEG + ascorbate: post hoc analysis of a randomised phase 3 clinical trial
16:24 •
Launching an Endoscopic Submucosal Dissection (ESD) program in a European academic hospital: review of the first 28 months of experience.
16:36 •
EUS today and tomorrow: what are we doing today in real practice in different countries and where are we going? : a Belgian survey.
16:50 •
Invited Lecture. Optical diagnosis: how do I do it?
17:20 •
Satellite Symposium BMS/PFIZER Alliance: Anticoagulation & GE : Where are we after 5 years of NOAC?
17:20 •
Satellite Symposium BMS/PFIZER Alliance: Anticoagulation & GE : Where are we after 5 years of NOAC?
Room TEUN (3th floor)
08:00 •
Breakfast Satellite Symposium Intercept: CHANGING PERSPECTIVES IN PRIMARY BILIARY CHOLANGITIS (PBC)
08:00 •
Breakfast Satellite Symposium Intercept: CHANGING PERSPECTIVES IN PRIMARY BILIARY CHOLANGITIS (PBC)
08:30 •
Screening for Hepatitis C at the emergency department: baby boomers should also be screened in Belgium
08:40 •
The thrombogenic risk induced by intraportal infusion of Adult Derived Human Liver Stem/Mesenchymal Cells in Wistar rats can be controlled with a combination of anticoagulant drugs, heparin and bivalirudin
08:50 •
Liver stiffness and steatosis evaluation by transient elastography in obese patients: baseline results analysis from a prospective Belgian study
09:00 •
Small for Size Syndrome and Hypoxia: lessons learned from the associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure in rats
09:10 •
A new "treatment-response score" for auto immune hepatitis is predictive of long-term event-free survival and overall survival. A multicenter Belgian cohort study
09:20 •
Generation of a unique liver progenitor cell gene signature to identify LPCs and LPC activation in chronic liver diseases
09:30 •
The outcome of acute-on-chronic liver failure in the intensive care is similar to a propensity matched ICU population without liver disease
09:40 •
Transcriptional repressors Zeb1 and Zeb2 regulate collagen production in drug-induced hepatic stellate cell activation in mice
09:50 •
Individualized prediction of the risk of liver-related death in patients with alcoholic cirrhosis
10:00 •
Coffee break
10:30 •
Is it too early to expand beyond the Milan Criteria for liver transplantation? A retrospective, multicentric study in Belgium
10:42 •
Transcriptomic profiling of intrahepatic B cells suggests a B-cell impairment in the Immune Active phase of Chronic Hepatitis B
10:54 •
Short and long-term survival of patients suffering from non-severe alcoholic hepatitis
11:06 •
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
11:18 •
Long-term outcome in patients with acute liver failure
11:30 •
BELIAC Lecture: Surgical management of early HCC
12:00 •
Satellite Symposium Abbvie: Towards the eradication of HCV
12:00 •
Satellite Symposium Abbvie : Towards the eradication of HCV
13:15 •
Satellite Symposium MSD: BEYOND THE EFFICACY OF HCV TREATMENTS, WHAT DOES REALLY MATTER? A PROS AND CONS DEBATE
13:15 •
Satellite Symposium MSD: BEYOND THE EFFICACY OF HCV TREATMENTS, WHAT DOES REALLY MATTER? A PROS AND CONS DEBATE
14:00 •
The effects of methoxamine and endotheline-1 on the increased transhepatic pressure gradient in a rat model of severe steatosis
14:12 •
Risk of hepatocellular cancer and fibrosis evolution in HCV patients treated with direct acting antiviral agents
14:24 •
The combination of N-acetylcysteine and anti-MT antibodies as novel therapy for acetaminophen-induced liver injury
14:36 •
The impact of pulmonary arterial hypertension therapy in patients with portopulmonary hypertension: a single tertiary center cohort analysis
14:48 •
Cytotoxic CD8 T lymphocytes are associated with “active” NASH: from the blood to the liver
15:00 •
MARC HAUTEKEETE LECTURE
16:00 •
Insulin resistance in cirrhotic patients : results from a large prospective study
16:10 •
Fibroscan is a useful and reliable tool to rule out advanced liver fibrosis and severe portal hypertension in alcoholic patients
16:20 •
The effects of NO modulators on the increased transhepatic pressure gradient in a rat model of severe steatosis
16:30 •
Estimation of the future liver remnant function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores
16:40 •
BASL Awards for best Basic and Clinical work presented
16:45 •
Satellite Symposium Gilead: Is nash the next HCV?
16:45 •
Satellite Symposium Gilead: Is nash the next HCV?
17:30 •
BASL General Assembly
Room TIFFANY/SHAH (2nd floor)
09:00 •
Predictors for colonic manometry outcome related to high-amplitude propagating sequences
09:15 •
Fecal Microbiota Transplantation in Irritable Bowel Syndrome with predominant abdominal bloating: results from a double blind, placebo-controlled, randomized controlled trial
09:30 •
Effects of Nafamostat Mesylate on intestinal permeability and bacterial translocation in an experimental model of sepsis
09:45 •
Invited Lecture: The touchy business of GI mucosal mechanosensitivity
11:00 •
Invited Lecture: Enteric neurons and mechanosensitivity: MEN at work
11:45 •
Mrgprc11 is expressed in murine viscerosensory spinal neurons: an immunohistochemical and retrograde tracing study
12:00 •
Live calcium imaging reveals neuronal circuitry differences in the mouse colon
12:15 •
Upregulation of mast cell related genes in irritable bowel syndrome
13:30 •
Lipids and irritable bowel syndrome – an (un)likely connection
14:15 •
Food antigen-specific sensitization of nociceptive nerves as an underlying mechanism of visceral pain in IBS
14:30 •
Double-blind randomized placebo-controlled trial of a probiotic combination ProbioTer in irritable bowel syndrome
14:45 •
Prospective study evaluating predisposing factors and immune- mediated mechanisms underlying post-infectious IBS
15:00 •
Long term adherence and effects of low FODMAP diet in patients with IBS
15:15 •
EfnB2 ligand as key player in visceral hypersensitivity
16:15 •
The circadian clock regulates diurnal rhythmicity of microbial short-chain fatty acid production and their rhythmic effects on colon contractility
16:30 •
Influence of the slow-release H2S donor GYY4137 and the H2S-releasing naproxen derivative ATB-346 on postoperative ileus
16:45 •
Effect of Resolvin D1, D2 and E2 on histamine-induced sensitization of TRPV1
17:00 •
In toto three-dimensional microscopical imaging of the intestinal wall: comparison of eight clearing protocols
17:15 •
Concluding remarks
Friday
, February 23
Exhibition Area (3th floor)
09:54 •
Coffee break
10:00 •
Coffee break
10:30 •
Coffee break
12:00 •
Lunch
12:15 •
Oral Top Clinical Posters
14:50 •
Coffee break
15:20 •
Coffee break
Room LIJN (3th floor)
09:00 •
Introduction
09:05 •
INVITED LECTURE : Non-HP gastritis
09:40 •
An unusual gastric polyp
09:50 •
Granular cytoplasmic expression of calretinin in Schwann cell hamartomas
10:45 •
INVITED LECTURE: Non-IBD colitis
11:20 •
Myxoid hepatocellular adenoma, a rare variant of liver cell adenoma, often clinically misdiagnosed as cavernous haemangioma
11:30 •
INVITED LECTURE: Auto-immune enteropathy
14:00 •
Introduction to the Brohée Prize
14:05 •
Brohée Prize Lecture: Personalized medicine in GI oncology: myth or reality
14:30 •
INVITED LECTURE: Neuroendocrine neoplasms of the GI tract: NET, NEC and MiNEN in the WHO 2017 classification
15:00 •
Frequency of epidermal metaplasia in a retrospective monocentric series of mucosectomy for esophageal intraepithelial neoplasia and/or superficial squamous cell carcinoma
15:10 •
Endothelial indoleamine 2,3-dioxygenase expression in colorectal cancer: an early marker of disease relapse
15:45 •
Case presentations of “Non-HP-gastritis” and “Non-IBD colitis”.
16:45 •
INVITED LECTURE: Disorders of the colon secondary to diagnostic procedures and treatments unrelated to drugs
Room SANCY (2nd floor)
09:00 •
Dynamic transrectal ultrasound versus MR defecography in patients with constipation
09:15 •
Injection of botulinum toxin in the treatment of anal fissure can be performed safely in patients actively receiving chemotherapy
09:30 •
Invited lecture: Sexually transmitted diseases of the anorectum
10:00 •
Hemorrhoidal disease in Belgian clinical practice: Results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research)
10:15 •
Thunderbeat®-assisted haemorrhoidectomy in symptomatic prolapsing haemorrhoids. A pilot trial.
11:00 •
Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis
11:10 •
Invited lecture: Manifestations of Human Papilloma Virus infection at the anal canal – anal intraepithelial neoplasia – early detection and prevention
11:40 •
What you’ve always wanted to know but never dared to ask: tips and tricks for frequent and unusual proctology cases (interactive session)
13:30 •
Diagnostic value of faecal calprotectine
13:50 •
Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
14:10 •
Human milk oligosaccharides in clinical studies
14:30 •
Gastric emptying in children in health and disease: an update for daily clinical practice
15:20 •
Infliximab trough levels after induction therapy are predictive for the outcome in paediatric patients with inflammatory bowel disease
15:30 •
Infliximab trough levels during maintenance are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
15:40 •
Medical devices in EU claiming oropharyngeal or gastrointestinal barrier action: barrier products or hidden pharmacological agents?
15:50 •
Diagnostic and therapeutic challenges in pediatric chronic pancreatitis
16:20 •
Immunological consequences of liver transplantation in children: making or breaking tolerance
16:40 •
General Assembly BeSPGHAN
Room TEUN (3th floor)
08:00 •
Breakfast Symposium ELI LILLY: Optimizing sequential treatment in gastric cancer
08:00 •
Breakfast Symposium ELI LILLY: Optimizing sequential treatment in gastric cancer
08:30 •
Prognostic value of tumor location in colorectal carcinoma: a Belgian population-based study
08:42 •
A novel post-surgical prognostic system for colorectal liver metastases treated by preoperative systemic treatment, using tumoral and non tumoral pathological changes, RAS mutation and Immunoscore
08:54 •
Preoperative gemcitabine-nab-paclitaxel (G-NP) for (borderline) resectable (BLR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC): a feasibility and proof of concept study
09:06 •
Impact of introduction of an enhanced recovery pathway in esopagheal cancer surgery: a prospective cohort study and propensity score matching analysis
09:18 •
Long term oncological results and quality of life after HIPEC for carcinomatosis of colorectal origin
09:30 •
Clinical Application and Potential Usefulness of Targeted Next-Generation Sequencing on Resected Pancreatic Ductal Adenocarcinoma
09:42 •
Inter-center heterogeneity in the quality of care for rectal adenocarcinoma in Belgium
10:30 •
Upper GI cancers
10:50 •
Hepato-Bilio-Pancreatic cancers
11:10 •
Colo-Rectal cancers
11:30 •
State-of-the-art lecture: “MSI testing in GI cancer: challenges and pitfalls”
12:00 •
Satellite Symposium SERVIER: Redefining third line therapy in metastatic colorectal cancer
12:00 •
Satellite Symposium SERVIER: Redefining third line therapy in metastatic colorectal cancer
13:15 •
Satellite Symposium BMS Oncology: Are we understanding immunotherapy? Challenges & Opportunities
13:15 •
Satellite Symposium BMS Oncology: Are we understanding immunotherapy? Challenges & Opportunities
14:00 •
Live Transmission: Lower gastro-intestinal endoscopy. Are we doing well? How can we do better?
Room TIFFANY/SHAH (2nd floor)
09:00 •
Welcome and introduction
09:15 •
Patient empowerment: The key to treatment success in IBD
09:45 •
Colon cancer in IBD: Natural history and recommendations for screening and surveillance
10:15 •
Therapeutic treatment with ustekinumab
10:45 •
Coffee Break
11:15 •
Psychological aspects of IBD
11:45 •
Dermatologic manifestations in IBD
12:15 •
Clinical studies for dummies
12:45 •
Closing of the program
13:00 •
LUNCH
14:00 •
BSGIE Live transmission
Timezone
bwge2018
Europe/Brussels
Filter By Date
bwge2018
Feb 21
-
23, 2018
Wednesday
, February 21
Thursday
, February 22
Friday
, February 23
Filter By Venue
Hilton, Antwerp, Belgium
Sort schedule by Venue
Exhibition Area (3th floor)
Room Florentine
Room HOPE (2nd floor)
Room LIJN (3th floor)
Room SANCY (2nd floor)
Room TEUN (3th floor)
Room TIFFANY/SHAH (2nd floor)
Filter By Type
Belgian Association for the Study of the Liver (BASL)
All
Session 1
Session 2
Session 3
Session 4
Belgian Group for Digestive Oncology (BGDO)
All
Session 'State of the art'
Session 1: Selected abstracts
Session 2: Highlights of the year
Symposium
Belgian Inflammatory Bowel Disease Research and Development Group (BIRD)
All
General Assembly
Session 1
Session 2
Session 3
Session 4
Belgian Network on Gastrointestinal Regulatory Mechanisms (GIREM)
All
Session 1
Belgian Pancreatic Club
All
Clinical cases session 1
Clinical cases session 2
Belgian Society for Gastrointestinal Endoscopy (BSGIE)
All
Guided e-Poster Tour
Live Transmission
Oral presentations & invited lectures
Belgian Society for Paediatric Gastroenterology and Nutrion (BeSPGHAN)
Belgian Working group on Digestive Pathology
All
Session 1
Session 2
Session 3
Session 4
Belgian Working Group on Proctology
BINAstoria
Interactive Case Report Session 1
Interactive Case Report Session 2
Oral Top Posters - Short talks
Satellite Symposia
All
Symposium
Ultrasound Course
Young BASL
All
Session 1
Session 2
Filter sessions
Apply filters to sessions.
close
Dates
Wednesday
, February 21
Thursday
, February 22
Friday
, February 23
Venue
Exhibition Area (3th floor)
Room Florentine
Room HOPE (2nd floor)
Room LIJN (3th floor)
Room SANCY (2nd floor)
Room TEUN (3th floor)
Room TIFFANY/SHAH (2nd floor)
Session Type
Belgian Association for the Study of the Liver (BASL)
All
Session 1
Session 2
Session 3
Session 4
Belgian Group for Digestive Oncology (BGDO)
All
Session 'State of the art'
Session 1: Selected abstracts
Session 2: Highlights of the year
Symposium
Belgian Inflammatory Bowel Disease Research and Development Group (BIRD)
All
General Assembly
Session 1
Session 2
Session 3
Session 4
Belgian Network on Gastrointestinal Regulatory Mechanisms (GIREM)
All
Session 1
Belgian Pancreatic Club
All
Clinical cases session 1
Clinical cases session 2
Belgian Society for Gastrointestinal Endoscopy (BSGIE)
All
Guided e-Poster Tour
Live Transmission
Oral presentations & invited lectures
Belgian Society for Paediatric Gastroenterology and Nutrion (BeSPGHAN)
Belgian Working group on Digestive Pathology
All
Session 1
Session 2
Session 3
Session 4
Belgian Working Group on Proctology
BINAstoria
Interactive Case Report Session 1
Interactive Case Report Session 2
Oral Top Posters - Short talks
Satellite Symposia
All
Symposium
Ultrasound Course
Young BASL
All
Session 1
Session 2
Other Filters
